CD276 and rheumatoid arthritis: Numerous studies have shown that aberrantly expressed costimulatory molecules participate in the pathological processes of multiple autoimmune diseases, including rheumatoid arthritis, systemic lupus erythematosus, asthma, and kidney disease in different ways by mediating the abnormal activation of immune cells during different phases of the immunopathological response24–28.